Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
76,378,254
-
Total 13F shares
-
26,194,106
-
Share change
-
-763,696
-
Total reported value
-
$168,954,836
-
Price per share
-
$6.45
-
Number of holders
-
59
-
Value change
-
-$3,601,715
-
Number of buys
-
23
-
Number of sells
-
25
Institutional Holders of Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX) as of Q4 2023
As of 31 Dec 2023,
Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,194,106 shares.
The largest 10 holders included
Flagship Pioneering Inc., FMR LLC, RAYMOND JAMES & ASSOCIATES, Euclidean Capital LLC, BlackRock Inc., VANGUARD GROUP INC, Artal Group S.A., Point72 Asset Management, L.P., Alphabet Inc., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
59
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.